HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Disruption of Proline Synthesis in Melanoma Inhibits Protein Production Mediated by the GCN2 Pathway.

AbstractUNLABELLED:
Many processes are deregulated in melanoma cells and one of those is protein production. Although much is known about protein synthesis in cancer cells, effective ways of therapeutically targeting this process remain an understudied area of research. A process that is upregulated in melanoma compared with normal melanocytes is proline biosynthesis, which has been linked to both oncogene and tumor suppressor pathways, suggesting an important convergent point for therapeutic intervention. Therefore, an RNAi screen of a kinase library was undertaken, identifying aldehyde dehydrogenase 18 family, member A1 (ALDH18A1) as a critically important gene in regulating melanoma cell growth through proline biosynthesis. Inhibition of ALDH18A1, the gene encoding pyrroline-5-carboxylate synthase (P5CS), significantly decreased cultured melanoma cell viability and tumor growth. Knockdown of P5CS using siRNA had no effect on apoptosis, autophagy, or the cell cycle but cell-doubling time increased dramatically suggesting that there was a general slowdown in cellular metabolism. Mechanistically, targeting ALDH18A1 activated the serine/threonine protein kinase GCN2 (general control nonderepressible 2) to inhibit protein synthesis, which could be reversed with proline supplementation. Thus, targeting ALDH18A1 in melanoma can be used to disrupt proline biosynthesis to limit cell metabolism thereby increasing the cellular doubling time mediated through the GCN2 pathway.
IMPLICATIONS:
This study demonstrates that melanoma cells are sensitive to disruption of proline synthesis and provides a proof-of-concept that the proline synthesis pathway can be therapeutically targeted in melanoma tumors for tumor inhibitory efficacy.
AuthorsGregory R Kardos, Hannah C Wastyk, Gavin P Robertson
JournalMolecular cancer research : MCR (Mol Cancer Res) Vol. 13 Issue 10 Pg. 1408-20 (Oct 2015) ISSN: 1557-3125 [Electronic] United States
PMID26082174 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright©2015 American Association for Cancer Research.
Chemical References
  • Neoplasm Proteins
  • RNA, Small Interfering
  • Proline
  • ALDH18A1 protein, human
  • Aldehyde Dehydrogenase
  • EIF2AK4 protein, human
  • Eif2ak4 protein, mouse
  • Protein Serine-Threonine Kinases
Topics
  • Aldehyde Dehydrogenase (genetics, metabolism)
  • Animals
  • Cell Line, Tumor
  • Cell Proliferation (physiology)
  • Female
  • Humans
  • Melanocytes (metabolism)
  • Melanoma (genetics, metabolism, pathology)
  • Mice
  • Mice, Nude
  • Neoplasm Proteins (biosynthesis)
  • Proline (biosynthesis)
  • Protein Serine-Threonine Kinases (genetics, metabolism)
  • RNA, Small Interfering (genetics)
  • Signal Transduction
  • Skin Neoplasms (genetics, metabolism, pathology)
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: